# reload+after+2024-01-23 09:45:20.176752
longBusinessSummary§The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
maxAge§86400
priceHint§2
yield§0.0081
totalAssets§19681460
navPrice§22.15
currency§USD
category§Health
ytdReturn§0.0127912
beta3Year§0.0
fundFamily§Invesco
fundInceptionDate§1623196800
legalType§Exchange Traded Fund
exchange§NGM
quoteType§ETF
shortName§Invesco Nasdaq Biotechnology ET
longName§Invesco Nasdaq Biotechnology ETF
firstTradeDateEpochUtc§1623418200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§6c369595-7f8d-364f-9273-eca71c64c27c
gmtOffSetMilliseconds§-18000000
trailingPegRatio§None
